Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Cook Jennifer E., Director. Director active across 3 companies, notably Denali Therapeutics Inc.. Cumulatively, 33 reports have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €11.7m. History available since 1 June 2021. The latest transaction was disclosed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Cook Jennifer E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Jennifer E. Cook, Administrateur, is linked to BridgeBio Pharma, Inc., Denali Therapeutics Inc. and Jazz Pharmaceuticals plc as a Director. She has 32 filings in total, and across the recent sample of 32 filings, the reported activity shows sales of EUR 11,693,973 between 2021-06-03 and 2026-07-13, with the modal transaction nature listed as Attribution.